Poly Medicure Limited has scheduled a series of one-on-one meetings with analysts and investors commencing May 26, 2026. The company officials will engage with four major entities over four days, adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meetings will be conducted in physical format across two locations. The Registered Office in New Delhi will host two sessions, while the company's Plant in Faridabad will accommodate the remaining interactions. The company has explicitly stated that no unpublished price sensitive information will be shared during these discussions.

Schedule of Meetings

The following table outlines the detailed schedule for the investor meets:

The company noted that the above schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company itself. Further details regarding the meetings are available on the official website of poly medicure .

Poly Medicure Limited has successfully completed the acquisition of Brazilian medical device company MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA through its wholly owned subsidiary Polymed Brazil LTDA. The transaction was finalized on April 29, 2026, with the company receiving information about the completion on April 30, 2026.

Acquisition Structure and Timeline

Polymed Brazil LTDA executed a Quota Purchase Agreement on April 29, 2026, acquiring 100% equity in MEDYNEO from its existing quotaholders. The acquisition process was completed on the same day, with Polymed Brazil LTDA taking operational control of MEDYNEO, making it a step-down subsidiary of Poly Medicure Limited.

Target Company Profile

MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA is a Brazilian limited liability company focused on the importation and commercialization of medical devices. The company was incorporated on July 24, 2025, and operates as a shell entity without past activities, operations, employees, or existing liabilities.

Strategic Rationale

The acquisition provides Poly Medicure with crucial market access capabilities in Brazil's medical device sector. MEDYNEO holds all necessary licenses, permits, and registrations required for legal operation in Brazil's medical device importation and commercialization business segment. This licensing framework enables Polymed Brazil LTDA to immediately commence commercial operations without the typical regulatory approval delays.

Regulatory Compliance

The transaction does not constitute a related party transaction, with no promoter or group company interests in the acquired entity. The acquisition required no governmental or regulatory approvals, streamlining the completion process. The company has disclosed the transaction under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring full regulatory compliance.

Market Expansion Impact

This acquisition represents Poly Medicure's strategic entry into the Brazilian medical device market through a clean corporate structure. By acquiring a company with established licensing but no operational history or liabilities, Poly Medicure gains immediate market access while maintaining operational flexibility for future business development in Brazil's growing healthcare sector.